Advanced Certificate in Data-Driven Pricing and Market Access
-- ViewingNowThe Advanced Certificate in Data-Driven Pricing and Market Access is a comprehensive course that addresses the growing industry demand for professionals skilled in data analysis and strategic pricing. This certificate course empower learners with essential skills to make data-driven decisions, optimize pricing strategies, and improve market access.
6,981+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ě´ ęłźě ě ëí´
100% ě¨ëźě¸
ě´ëěë íěľ
ęłľě ę°ëĽí ě¸ěŚě
LinkedIn íëĄíě ěśę°
ěëŁęšě§ 2ę°ě
죟 2-3ěę°
ě¸ě ë ěě
ë기 ę¸°ę° ěě
ęłźě ě¸ëśěŹí
⢠Advanced Data Analysis for Pricing Strategy – This unit covers the application of advanced data analysis techniques to inform pricing strategy, including regression analysis, cluster analysis, and conjoint analysis.
⢠Market Access & Payer Negotiations – This unit explores the complex landscape of market access and payer negotiations, providing insights into the strategies and tactics used to secure optimal pricing and reimbursement.
⢠Health Economics & Outcomes Research (HEOR) – This unit delves into the role of health economics and outcomes research in informing pricing decisions, including the use of cost-effectiveness analysis and budget impact analysis.
⢠Pricing in Global Markets – This unit examines the unique challenges and opportunities associated with pricing products in global markets, including considerations related to exchange rates, cultural differences, and regulatory requirements.
⢠Pricing in Specialty Markets – This unit focuses on the complexities of pricing in specialty markets, such as oncology, rare diseases, and orphan drugs, where patient populations are small and treatment costs are high.
⢠Market Access & Pricing in Emerging Markets – This unit explores the challenges and opportunities associated with market access and pricing in emerging markets, including considerations related to regulatory frameworks, economic development, and cultural factors.
⢠Advanced Pricing Models – This unit delves into the use of advanced pricing models, including tiered pricing, value-based pricing, and indication-based pricing, to optimize revenue and access.
⢠Real-World Evidence (RWE) for Pricing & Market Access – This unit covers the role of real-world evidence in informing pricing and market access decisions, including the use of observational studies, patient registries, and other data sources.
⢠Pricing & Market Access in Digital Health – This unit explores the unique challenges and opportunities associated with pricing and market access for digital health products, including considerations related to data privacy, security, and interoperability.
ę˛˝ë Ľ 경ëĄ
ě í ěęą´
- 죟ě ě ëí 기본 ě´í´
- ěě´ ě¸ě´ ëĽěë
- ěť´í¨í° ë° ě¸í°ëˇ ě ꡟ
- 기본 ěť´í¨í° 기ě
- ęłźě ěëŁě ëí íě
ěŹě ęłľě ěę˛Šě´ íěíě§ ěěľëë¤. ě ꡟěąě ěí´ ě¤ęłë ęłźě .
ęłźě ěí
ě´ ęłźě ě ę˛˝ë Ľ ę°ë°ě ěí ě¤ěŠě ě¸ ě§ěęłź 기ě ě ě ęłľíŠëë¤. ꡸ę˛ě:
- ě¸ě ë°ě 기ę´ě ěí´ ě¸ěŚëě§ ěě
- ęśíě´ ěë 기ę´ě ěí´ ęˇě ëě§ ěě
- ęłľě ě겊ě ëł´ěě
ęłźě ě ěąęłľě ěźëĄ ěëŁí늴 ěëŁ ě¸ěŚě뼟 ë°ę˛ ëŠëë¤.
ě ěŹëë¤ě´ ę˛˝ë Ľě ěí´ ě°ëŚŹëĽź ě ííëę°
댏롰 ëĄëŠ ě¤...
ě죟 돝ë ě§ëŹ¸
ě˝ě¤ ěę°ëŁ
- 죟 3-4ěę°
- 쥰기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- 죟 2-3ěę°
- ě 기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- ě 체 ě˝ě¤ ě ꡟ
- ëě§í¸ ě¸ěŚě
- ě˝ě¤ ěëŁ
ęłźě ě ëł´ ë°ę¸°
íěŹëĄ ě§ëś
ě´ ęłźě ě ëšěŠě ě§ëśí기 ěí´ íěŹëĽź ěí ě˛ęľŹě뼟 ěě˛íě¸ě.
ě˛ęľŹěëĄ ę˛°ě ę˛˝ë Ľ ě¸ěŚě íë
